Why old-school payer-provider partnerships don’t cut it in today’s marketplace and a new kind of partnership is gaining hold.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A comprehensive view of the ACO market, including a detailed look at “winners”, regional differences, and success rates by type.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Oliver Wyman analysis details the performance of ACOs by type (physician-led, hospital-led, commercial) and offers insight into what it will take for each to be successful.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Despite changing political winds, value-based initiatives are as relevant as ever. Read new analysis of the ACO market and insight into next, best moves.

Partner, Health & Life Sciences, Oliver Wyman

Why old-school payer-provider partnerships don’t cut it in today’s marketplace and a new kind of partnership is gaining hold.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

An insurance start-up, a venerable health system, and a new kind of payer-provider partnership.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A detailed look at how one system pivoted from volume to value in just 12 months.

President and CEO of Envision Genomics, Chair-Elect of AMGA, Vice-Chair of HHS' PTAC
Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A perspective on how pediatric healthcare providers are changing their financial and care models in the evolving value-based market to lower costs and improve outcomes in children’s health.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Trion/MMA

OWHIC recently convened a group of market leaders to explore the disconnect between today’s de facto consumer marketplace and consumer-centric innovations.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman

The number of chronically ill and poor patients is growing as more people at the margins are receiving insurance coverage through Medicaid. Oliver Wyman research that suggests proper care for these patients, including meeting social needs such as mental illness, addiction, and poverty, could save $300 billion annually.

Global Head, Health Services, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More